Dr. Ike Ahmed

MD FRCSC

Prof. Amar Agarwal

M.S., FRCS, F.R.C.Ophth

Prof. Norbert Pfeiffer

Medical Director, Mainz University Medical Center

Dr. Ronald Fellman

Dr. Davinder Grover

MD MPH

Prof. Thomas Samuelson

Dr. Richard A Lewis

Prof. Xing-Huai Sun, MD  

Prof.

Minimally Invasive Micro Sclerostomy (MIMS®) is a Stentless, simple and fast Glaucoma treatment which effectively lowers the intraocular pressure (IOP) without the need for major invasive surgery.

News & Publications

Outstanding Clinical Performance

MIMS® is a rapid and minimal invasive procedure at the forefront of interventional glaucoma treatments. Fewer post-op complications allow for effective IOP management. MIMS® is designed to create a sclerostomy similar to trabeculectomy, the gold standard for incisional glaucoma surgery, but with an approach that is less invasive, in terms of tissue damage, and without any implanted material (stent-less). Therefore, complications relating to hyphema and hypotony (such as flat anterior chamber, choroidal effusions and detachments), which are observed in trabeculectomy are expected to occur at a lower incidence and severity with MIMS®. Other post-operative events are expected to be similar to other minimally invasive, stent-less glaucoma treatments.  

A Minimal invasive and Stent-less Treatment Glaucoma Innovation

Minimally Invasive Micro Sclerostomy (MIMS®) is fast, accessible and effective. MIMS® is intended for the reduction of elevated IOP. It works by inserting a specially designed cutting tool into the sclera and removing a small channel of tissue. This channel will remain open and continuously drain, effectively reducing IOP.MIMS® advantages:<ul><li>A minimal surgical intervention into the eye with the</li><li>consequent lower risk of hypotony or injury to the surrounding ocular tissues</li><li>enables stable post-operative IOP levels</li><li>Takes short surgical time (few minutes)</li><li>MIMS® application is simple and easy</li></ul>

How MIMS® Works

MIMS® is a lightweight surgical system intended for use by trained professional ophthalmologists. It’s easy to use and learn, intuitive to operate and requires fewer staff to assist in non-surgical environments. A central control touchscreen demonstrates the surgical parameters, and a foot pedal initiates the precise handheld cutting tool movement.

A Ready-to-Use Surgical System

Learn more about Sanoculis and MIMS® surgical device innovation.

Precision Glaucoma Treatment Technology

MIMS® Testimonials

Nir Israeli

Vadim Shmukler

COO&CTO

Dr. Yossi Glovinsky

Chief Medical Officer

Elad Shalev

VP Marketing & Sales

Erna Kidron

Global Head- Product & Surgical Specialists

Maayan Noach-Shaharabani

VP QA&RA 

Khan Lau OD, FAAO

VP Clinical Affairs US

Yerenavs

Viselle Augenzentrum

Barzilai Medical Center

Hadasa

Samaon Assuta

Hillel Yaffe Medical Institute

Medizin University

Medica

Swiss Visio - Montchoisi

Sanoculis LTD. develops the MIMS® solution for Glaucoma surgery treatment. Our vision is to become the gold standard for effective glaucoma surgery.

Our Vision

Home

Our Vision

Interventional Glaucoma

Clinical Trial Data

Distributors Login

Contact

Contact

Menu

Our Vision

Sanoculis Leadership Team

Sanoculis Medical Advisory Board

Medical Institutional Partners

Learn

Resources

Company